News from relmada therapeutics, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 26, 2016, 08:30 ET Relmada Therapeutics to Present at the 5th Annual Marcum MicroCap Conference

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...


May 16, 2016, 08:30 ET Relmada Therapeutics Announces Promotion of Michael D. Becker to Chief Financial Officer

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced...


May 04, 2016, 08:30 ET Relmada Therapeutics Announces Results of In Vivo Study Showing d-Methadone has Antidepressant-like Effects

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, today...


Apr 28, 2016, 08:30 ET Relmada Therapeutics to Present at the Joseph Gunnar "Pioneers 2016" Conference

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced...


Apr 26, 2016, 08:30 ET Relmada Therapeutics Provides Additional Details Regarding Upcoming R&D Day

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, today...


Apr 20, 2016, 08:30 ET Relmada Therapeutics to Showcase Breadth of Pipeline at Upcoming R&D Day

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced...


Apr 14, 2016, 08:30 ET Relmada Therapeutics, Inc. Provides Update on Nasdaq Up-Listing Process

Relmada Therapeutics, Inc. (OTCQB: RLMD) a clinical-stage company developing novel therapies for the treatment of chronic pain, today provided...


Mar 08, 2016, 08:00 ET Relmada Therapeutics to Present at the 28th Annual ROTH Conference

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, today...


Mar 01, 2016, 08:00 ET Relmada Therapeutics Announces Publication of Full Results from Phase I Study Showing Treatment with d-Methadone to be Safe and Well Tolerated

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company), a clinical-stage company developing novel therapies for the treatment of...


Feb 02, 2016, 08:00 ET Relmada Therapeutics to Present at the 18th Annual BIO CEO & Investor Conference

Relmada Therapeutics, Inc. (OTCQB: RLMD) a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today...


Jan 26, 2016, 07:00 ET Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...


Jan 11, 2016, 08:00 ET Relmada Therapeutics Selected to Present at 2016 Biotech Showcase™ in San Francisco

 Relmada Therapeutics, Inc. (OTCQB: RLMD) a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...


Jan 04, 2016, 08:00 ET Relmada Therapeutics Successfully Completes Multiple Ascending Dose Study of d-Methadone for Neuropathic Pain

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company), a clinical-stage company developing novel therapies for the treatment of...


Dec 30, 2015, 11:55 ET Relmada Therapeutics Announces Results of Annual Meeting of Stockholders

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or "the Company"), a clinical-stage company developing novel therapies for the treatment...


Dec 28, 2015, 08:30 ET Relmada Therapeutics Recommends Stockholders Vote "FOR" Relmada's Director Nominees on the WHITE Proxy Card Today

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...


Dec 23, 2015, 08:30 ET U.S. Federal Court Grants Preliminary Injunction Against Laidlaw & Company and its Principals Matthew Eitner and James Ahern

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...


Dec 21, 2015, 08:00 ET Relmada Sends Letter To Stockholders Highlighting Significant Progress In Value Creation Strategy Overseen By Board And Management Team

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...


Dec 15, 2015, 08:30 ET Leading Independent Proxy Advisory Firm Glass Lewis Recommends Relmada Stockholders Vote the WHITE Proxy Card "FOR" Relmada's Director Nominees: Shreeram Agharkar and Maged Shenouda

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...


Dec 14, 2015, 08:30 ET Pharmaceutical Industry Leader James Dolan Joins Relmada Therapeutics Advisory Team

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the...


Dec 11, 2015, 09:15 ET U.S. Federal Court Issues Temporary Restraining Order Against Laidlaw & Company and its Principals Matthew Eitner and James Ahern

Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment of...


Dec 10, 2015, 08:00 ET Relmada Therapeutics Announces Additional Information Regarding Positive Topline Results for Proof-of-Concept Study with BuTab

 Relmada Therapeutics, Inc. (OTCQB: RLMD) a clinical-stage company developing novel therapies for the treatment of chronic pain, today...


Dec 09, 2015, 16:15 ET Relmada Therapeutics Announces Positive Topline Results for Proof-of-Concept Study with BuTab

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, today...


Dec 09, 2015, 09:26 ET Relmada Therapeutics Files Federal Lawsuit Against Laidlaw & Company and its Principals Matthew Eitner and James Ahern to Protect Interests of Relmada Stockholders

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...


Dec 07, 2015, 07:45 ET Relmada Therapeutics to Mail Letter to Stockholders Highlighting Laidlaw & Company's Questionable Business Practices and Conduct

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...


Dec 01, 2015, 09:24 ET Relmada Therapeutics to Present at LD Micro Main Event

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today...